The metabolic advantage of tumor cells
2011
The Metabolic Advantage of Tumor Cells
publication
Evidence: moderate
Author Information
Author(s): Israël Maurice, Schwartz Laurent
Hypothesis
Tumor cells have a unique metabolism that provides them a selective advantage over normal cells.
Conclusion
Tumor cell metabolism allows them to efficiently utilize glucose while consuming muscle protein and lipid stores, giving them a growth advantage.
Supporting Evidence
- Tumor cells exhibit increased glycolysis and lactate production, known as the Warburg effect.
- Hexokinase 2 in tumor cells enhances glycolysis while inhibiting apoptosis.
- Pyruvate kinase M2 is a key enzyme that is inhibited in tumor cells, creating a metabolic bottleneck.
- Choline and methylation play a role in regulating tumor metabolism and may influence cancer progression.
- Insulin and IGF signaling pathways are often dysregulated in tumors, contributing to their metabolic advantages.
Takeaway
Tumor cells have a special way of using energy that helps them grow faster than normal cells, even when they are starving.
Methodology
The study reviews various biochemical pathways and metabolic processes in tumor cells, highlighting their differences from normal cells.
Limitations
The review is based on existing literature and may not include all recent findings.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website